ARK Sells Off Shares in Twist Bioscience and More

Cathie Wood's ARK ETF has made significant changes to its portfolio, selling off shares in several companies and buying more of another. The most notable sale was 46,015 shares of Twist Bioscience Corporation, worth $5,837,002, which continues a recent trend of reducing the fund's position in the company.

ARK also sold shares in 10X Genomics, Inc., Bullish, Tempus AI, Inc., GeneDx Holdings Corp., and Alphabet Inc. The sales indicate a strategic reallocation of the portfolio, with ARK pivoting its focus to capitalize on emerging opportunities.

The buying activity was largely focused on Intellia Therapeutics, Inc., which ARK has been steadily increasing its position in over the past week. The fund purchased 114,989 shares worth $1,371,818.